Given that imipridones inhibit cell proliferation and tumor growth through effects on the AKT/mTOR pathway in EC36, we next investigated whether the AKT/mTOR pathway was involved in the synergistic anti-proliferative effects of olaparib and ONC206 in the EC cell lines. Here, AKT1 is linked to neoplasm.